SOURCES SOUGHT
65 -- Sources Sought for Third Party Logistics Provider to Warehouse and Distribute Medical Supplies - DRAFT PERFORMANCE STATEMENT OF WORK RFI102363PL
- Notice Date
- 8/24/2010
- Notice Type
- Sources Sought
- NAICS
- 493110
— General Warehousing and Storage
- Contracting Office
- Defense Logistics Agency, DLA Acquisition Locations, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, Pennsylvania, 19111-5096, United States
- ZIP Code
- 19111-5096
- Solicitation Number
- RFI102363PL
- Point of Contact
- Melissa McMichael, Phone: 2157374296
- E-Mail Address
-
Melissa.McMichael@dla.mil
(Melissa.McMichael@dla.mil)
- Small Business Set-Aside
- N/A
- Description
- Draft of the Performance Work Statement This is a SOURCES SOUGHT NOTICE: This notice is issued for information and planning purposes only and does not constitute a solicitation. The Government does not intend to award a contract on the basis of this RFI or to otherwise pay for information received in response to this RFI. All information received in response to this RFI that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. Information provided in response to this RFI will be used to assess tradeoffs and alternatives available for determining how to proceed in the acquisition process. Responders are solely responsible for all expenses associated with responding to this RFI. The Defense Logistics Agency (DLA) Troop Support Medical Directorate is issuing a Request for Information (RFI) seeking a third party logistics (3PL) provider to initially manage, receive, stow, maintain inventory records, storage, packaging, transportation, shipment documentation, shipment tracking data and reporting of the Pandemic Influenza products. These products include but are not limited to Probenecid, Rimantadine, Relenza, several antibiotics, and N95 masks. The scope of the requirement is not limited to these identified products as other pharmaceutical and medical products may later be identified and added to any resultant contract. PROGRAM OVERVIEW The DLA Troop Support is examining the potential for a third party logistics provider to receive/store/distribute pandemic influenza products for the DLA Troop Support Medical Directorate on behalf of the Department of Defense Health Affairs Pandemic Influenza Program and other DoD agencies. The vendor is required to provide receipt, warehousing, inventory management, packaging, and transportation of various pharmaceutical and medical products. In addition, upon Government direction the 3PL supplier shall prepare shipment documentation, packaging, and shipping via traceable means to customer activities throughout CONUS (Contiguous United States) plus Hawaii, Alaska and Puerto Rico under FOB Destination procedures. Item Qty 1. Rimantadine (bottles of 100) 170,000 to 220,000 Bottles 2. Probenecid (bottles of 100) 25,000 Bottles 3. Relenza 670,000 to 685000 Units 4. N95 masks 9.6 to 14.4 million 5. Amoxicillin & Clavulante Potassium (20 Tablets) 8000 Bottles 6. Amoxicillin & Clavulante Potassium Oral Susp (400mg/5ml) 17,000 Bottles 7. Cefepime 2gm,IV, 20ml (10 vials per package) 8000 packages 8. Ceftriaxone Inf, 1gm (10 or 25 vials per package) 80,000 Doses 9. Doxycycline Hyclate Inj 100 mg (packages of 10) 8,000 packages 10. Doxycycline 100 mg (500 tabs) 325 bottles 11. Imipenem & Cilastin Inj, 500/500 mg (25 per package) 4550 packages 12. Levofloxacin 25mg/ml Inj (30ML SDV) 85,000 SDV 13. Levofloxacin Tabs, 750 mg U/D 100"s 850 Bottles 14. Vancomycin HCL 1gm 10 VI/PG 24,000 packages Estimated shelf-life of products upon receipt is 20 to 36 months; except N95 masks that are non shelf life items. These products shall be stored at controlled and non-controlled room temperatures depending on products' warehousing specifications. The pharmaceutical products shall be warehoused under Controlled Room Temperature of 68 degree Fahrenheit to 77 degrees Fahrenheit with excursions between 59 and 86 degree Fahrenheit. All material shall be warehoused in accordance and in compliance with United States Pharmacopeia (USP) Chapter 1079, "Good Storage and Shipping Practices" and Chapter 1118, "Monitoring Devices - Time Temperature, and Humidity". The 3PL facility must be approved to handle Controlled Room Temperatures in accordance with Current Good Manufacturing Practices and meet all FDA regulatory requirements to warehousing pharmaceuticals. The goal of this initiative is to have a supply of these pharmaceutical and medical products readily available for shipment/transportation in the event of an influenza pandemic or other public health emergency. Upon notification 3PL suppliers would be expected to have product shipped within 24 hours and delivered within 48 hours to CONUS activities plus Alaska, Hawaii and Puerto Rico. Anticipated Scope of Services: Warehousing - The ability to receive, store and manage these pharmaceutical and medical products in a secure, controlled room temperature environment while maintaining shelf-life requirements. Inventory accountability will be at the unit of sale level; which is "Bottle", "Package", "Vial", "SDV", etc. Receiving - Acknowledging receipt of inventory from manufacturers. Validating and reporting inventory quantities received. Handling any associated discrepancies in receiving said products from incorrect quantities, shelf-life issues, and damaged material. Distribution - Packaging, labeling and transporting the products to the end user to include providing traceable shipment tracking data to Government point of contact and entering said data into Government web supplier order management system. Prepare shipment documentation to include shipping labels. Ensure that shortest dated material is shipped out first. Outbound shipment quantities will be at the "bottle", "package", "vial", "SDV", etc. level count; for example: 10 bottles, 1 bottle, 24 bottles, etc. Data Management - to include interoperability with industry and government systems. RFI Questions 1) Warehousing a. What is your concept for the warehousing requirements to support this effort? b. Does your company have experience with warehousing pharmaceutical and medical products? c. What are your capabilities for warehousing these pharmaceutical and medical products with the requirements set forth? d. Would you be able to re-label the product packaging if needed? e. Describe your procedure for managing/recording the products' shelf-life. f. Are there any additional measures that would need to be taken to ensure the security of the facility? If so what would they be? g. Do your 3PL facilities that store pharmaceuticals comply with U.S. Pharmacopeia 1079 and 1118 standards? h. Do your 3PL facilities that store pharmaceuticals and medical items maintain back-up storage space for all assets and plans to respond to a natural or manmade disaster that would require rapid relocation of assets? i. Do your 3PL facilities that store pharmaceuticals have back-up power for key facility components, including all temperature-controlled environments, and all temperature-monitoring, temperature-recording, temperature-alarm systems, as well as security alarm systems? j. Do your 3PL facilities that store pharmaceuticals have back-up procedures for monitoring temperature? k. Do your 3PL facilities that store pharmaceuticals have a Highly Protected Risk (HPR) designation, signifying higher-than-average safety standards and compliance with the industry's most stringent level of risk protection? 2) Distribution a. Describe your current procedures for reporting shipping/tracking information to the customer etc. b. Does your company have experience with distributing medical and or pharmaceutical products? c. What are your capabilities for shipping material OCONUS (outside contiguous United States) if the request was overseas? d. What data fields are included on your packing slip? Are you capable of adding information such as pharmaceutical and medical product Lot Numbers? e. Could your company ship material within 24 hours after receipt of order and ensure delivery to CONUS activities plus Hawaii, Alaska and Puerto Rico within 48 hours? If not, what would be your minimum timeframes for shipping and delivery? f. Describe your current procedures for shipping material listed as a "Controlled Room Temperature" product. 3) Data Management a. What type of data systems do you currently use and do you see any concerns with integrating your IT systems with other industry partners and government agencies? b. Describe your IT capabilities as it pertains to accepting/processing customer orders. c. Does your company have Electronic Data Interchange (EDI) capability? d. Do your 3PL facilities that store pharmaceuticals have data back-up for all electronic and temperature-monitoring systems? e. Do your 3PL facilities that store pharmaceuticals and medical products have redundant servers and a solid data backup strategy? 4) General Business Information a. What would be some of the General and Administrative and Overhead costs you would predict for managing this type of program? Are the following applicable? What would you add or delete? 1. All Information Technology Systems costs including hardware, software, servers and programming. 2. All Facilities costs including lease/rent, insurance, overhead, alarm/sprinkler systems, racking, shelving 3. All Labor costs. 4. All Material Handling Equipment (MHE) costs such as forklifts, dollies, pallet jacks, ladders and lifts. 5. All Packaging costs including packaging supplies, labels, bar-coding supplies, package marking supplies, stretch/shrink wrap, dunnage. 6. All costs associated with attending or hosting meetings or program management reviews. b. What is your customary method for charging this type of warehouse and distribution requirement? Is there a fee schedule you would charge based on number of pallets stored? Square foot or cubic foot of storage space used? c. All items stored under this requirement may be ordered to the unit level i.e. 1 bottle. Material is being stored in the case of an emergency. Material could be stored for years without issue or in the event of a Pandemic, several hundred issues could be made in a 24 hour period. 1. How would you charge for shipping each order? Would the shipping charge be applied based on the weight of the order? Manufacturer Packaging Specifications and weights for the pharmaceutical and medical products are as follows: 1. Rimantadine (Flumadine), 100's 12 bottles per case 660 cases per pallet (55 cases x 12 layers) Case dimensions:.65 x.52 x.33 (in) Pallet dimensions: 45 x 40 x 39 (in) Bottle weight: 0.08 (lbs) Case weight: 1.05 (lbs) Pallet weight: 755 (lbs) 2. Probenecid, 100's 12 bottles to carton 144 bottles to case (12 cartons) 864 bottles to one layer on pallet (6 cases) 2592 bottles to a pallet (18 cases) Bottle and case weight are currently unavailable for this product. Pallet weight: 576 lbs. Pallet cube: 40"x48"x39" Layer weight: 192 lbs. Layer cube: 40"x48"x13" 3. Relenza 16 units to package 1,120 units to a pallet Pallet dimension: 48 x 40 x 47 (in) Unit weight: 0.02 (lbs) Pallet weight: 264 (lbs) 4. N95 masks (requirement requests different mask sizes; range of dimensions below) Pallet dimension: 40 x 48 x 40 (in) 20 masks per box 6 boxes per case (carton) - (120 masks) 9 to 12 layers to one layer on pallet 40 to 60 cases per pallet (4,800 to 7,200 masks) Case weight: 3.5 to 4.77 lbs 5. Amoxicillin and Clavulanate Potassium, 20 Tabs 400 bottles to case 18 cases to a pallet (7,200 bottles) Case weight: 22 lbs. Cubic feet per case: 1.77 6. Amoxicillin and Clavulanate Potassium Oral Susp (400mg/5ml), bottles 24 bottles to case 120 cases to a pallet (2,880 bottles) Case weight: 3.3 lbs Cubic feet per case:.296 7. Cefepime 2gm, IV, 20ml, add-vantage, 10 vials per package 24 packages to a case 32 cases to a pallet (768 packages) Case weight: 26 lbs Cubic feet per case: 0.98 8. Ceftriaxone Inj 1gm, 10 vials per package 24 packages to a case 32 cases to a pallet (7,680 vials) Case weight: 26 lbs Cubic feet per case: 0.98 Ceftriaxone Inj 1gm, 25 vials per package 4 packages to a case 120 cases to a pallet (12,000 vials) Case weight: 14.05 lbs Cubic feet per case: 0.48 9. Doxycycline Hyclate Inj 100mg 10 packages to a case 140 cases to a pallet (1,400 packages) Case weight: 6 lbs Cubic feet per case: 0.29 10. Doxycycline 100mg (500 tabs), bottles 24 bottles to case 84 cases to a pallet (2,016 bottles) Case weight: 8.715 lbs Cubic feet per case: 0.4521 11. Imipenem & Cilastin Inj, 500/500 mg, 25 per package 16 packages to a case 27 cases to a pallet (432 packages) Case weight: 22.18 lbs Cubic feet per case: 1.26 12. Levofloxacin 25mg/ml Inj., 30ml SDV 60 packages per case 60 cases per pallet Case weight: 9.11 lbs Cubic feet per case: 0.37 13. Levofloxacin Tabs, 750 mg U/D 100's 10 packages per case 96 cases per pallet Case weight: 4.44 lbs 14. Vancomycin HCL 1gm 10VI/PG 10 packages to a case 144 packages to a pallet (1,440) Case weight: 6.3 lbs Cubic feet per case:.258 d. What is your customary practice for warehouse receipt and issues? How do you charge for receipts and issues? As general overhead fee or per issue or receipt? Given the uncertainty of issues, how would you charge for issues and receipts under this requirement? e. Describe any risks/obstacles you foresee with this initiative and how you would mitigate those risks. 5) Budgetary Estimate a. If possible please provide a budgetary level annual estimate for this project. 1. Assume at least 2 shipments, into your warehouse, for each product per year. a) What would be your costs for receipt? 2. Assume your company will be storing stated # of pallets. a) What would be your quarterly estimate of costs for receiving and storage for listed material and quantities? 3. Assume any issues would be 1 each to 1 case per destination. a) What would be your transportation costs? b) What would be the packaging/ labeling costs based on 1 each or 1 case? 6) Miscellaneous a. Are you considered to be a manufacturer or distributor of Medical products including pharmaceuticals? b. If your company is considered a Small Business under the proposed NAICS codes 493110 do you foresee any impediments in support of this initiative? 1. Does your company qualify in any sub-category? (i.e. 8(a), HUBZone, SDVOSB, WOSB) c. Is your company considered a small or large business under this classification? d. Is your company currently listed in the Central Contractor Registry? Contractors may obtain information or registration and annual confirmation requirements via the Internet at http://www.ccr.gov or by calling 1-888-227-2423, or 269-961-5757. SUMMARY Please send your responses to the RFI questions to the following P.O.C.s by September 7, 2010: Melissa McMichael, Acquisition Specialist, Email: mailto:melissa.mcmichael@dla.mil. cc: Rosemary Adams, Team Lead, Email: mailto:rosemary.adams@dla.mil
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DLA/J3/DSCP-M/RFI102363PL/listing.html)
- Record
- SN02252536-W 20100826/100824235215-5f9334c696ae4db5f76086d0c625ca8c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |